Black Diamond Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -117.1% | – | – | – | – | – | |
| – | -25.2% | +0.0% | +0.0% | +0.0% | -1.2% | +2.4% | -1.1% | +0.0% | -23.3% | -59.1% | +3.7% | – | |
| – | -44.2% | +11.5% | +208.6% | -62.3% | -17.9% | +3.9% | +4.5% | -2.1% | -18.8% | +2.5% | +4.4% | – | |
| – | +216.3% | -216.4% | – | +1,041.0% | -133.0% | – | – | – | – | – | – | – | |
| – | +0.0% | -100.0% | – | +0.0% | -100.0% | – | – | – | – | – | – | – | |
| – | – | -212.1% | – | +196.4% | +1,166.3% | -69.2% | -792.1% | – | -133.6% | – | -116.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.1% | – | +417.6% | -101.2% | – | -89.0% | -462.5% | – | -246.3% | -5.6% | – | – | |
| – | -111.2% | – | – | -227.0% | – | +376.7% | -210.4% | – | -1,229.5% | – | -210.6% | – | |
| – | – | – | – | – | – | – | -117.1% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.